About Small Pharma
Small Pharma is a company based in London (United Kingdom) founded in 2015 was acquired by Cybin in August 2023.. Small Pharma has raised $49.17 million across 7 funding rounds from investors including Gov.uk, Canaccord Genuity Group and Cybin. The company has 9 employees as of February 28, 2021. Small Pharma offers products and services including CYB003 and CYB004. Small Pharma operates in a competitive market with competitors including GH Research, Lykos and Ketabon, among others.
- Headquarter London, United Kingdom
- Employees 9 as on 28 Feb, 2021
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Small Pharma Ltd
-
Annual Revenue
$58.28 K (USD)-52as on Feb 28, 2021
-
Net Profit
$-13.74 M (USD)-145as on Feb 28, 2022
-
EBITDA
$-14.26 M (USD)-155as on Feb 28, 2022
-
Total Equity Funding
$49.17 M (USD)
in 7 rounds
-
Latest Funding Round
$46.02 M (USD), Series A
Mar 09, 2021
-
Investors
Gov.uk
& 8 more
-
Employee Count
9
as on Feb 28, 2021
-
Acquired by
Cybin
(Aug 28, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Small Pharma
Small Pharma offers a comprehensive portfolio of products and services, including CYB003 and CYB004. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets Major Depressive Disorder through psychedelic innovation
Addresses Generalized Anxiety Disorder via novel formulations
Funding Insights of Small Pharma
Small Pharma has successfully raised a total of $49.17M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $46.02 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $46.0M
-
First Round
First Round
(18 Aug 2015)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series A - Small Pharma | Valuation | Canaccord Genuity Group , Eight Capital |
|
| Jul, 2019 | Amount | Seed - Small Pharma | Valuation | AI Fund , o2h ventures |
|
| Dec, 2018 | Amount | Seed - Small Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Small Pharma
Small Pharma has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Gov.uk, Canaccord Genuity Group and Cybin. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI Fund is operated as a venture studio for AI startups.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on angel investments
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Small Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Small Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Small Pharma Comparisons
Competitors of Small Pharma
Small Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GH Research, Lykos and Ketabon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for mental disease management are developed using 5-MeO-DMT formulations.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat mental health conditions
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutics for treatment-resistant depression.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Small Pharma
Frequently Asked Questions about Small Pharma
When was Small Pharma founded?
Small Pharma was founded in 2015.
Where is Small Pharma located?
Small Pharma is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Small Pharma a funded company?
Small Pharma is a funded company, having raised a total of $49.17M across 7 funding rounds to date. The company's 1st funding round was a Seed of $197.22K, raised on Aug 18, 2015.
How many employees does Small Pharma have?
As of Feb 28, 2021, the latest employee count at Small Pharma is 9.
What is the annual revenue of Small Pharma?
Annual revenue of Small Pharma is $58.28K as on Feb 28, 2021.
What does Small Pharma do?
Small Pharma was founded in 2015 in London, United Kingdom. Psychedelic-based therapeutics targeting mental health conditions are developed within the biotechnology sector. Tryptamine-based drug candidates are formulated using proprietary deuterium enriching technology. Operations center on advancing the pipeline, which includes SPL026, SPL028, SPL029, and SPL801 as injectable and oral DMT therapies for depressive disorder.
Who are the top competitors of Small Pharma?
Small Pharma's top competitors include GH Research, Lykos and Ketabon.
What products or services does Small Pharma offer?
Small Pharma offers CYB003 and CYB004.
Who are Small Pharma's investors?
Small Pharma has 9 investors. Key investors include Gov.uk, Canaccord Genuity Group, Cybin, AI Fund, and o2h ventures.
What is Small Pharma's valuation?
The valuation of Small Pharma is $4.19M as of Jul 2019.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.